Taiwan is a well-known endemic area of hepatitis B. Hepatocellular carcinoma (HCC) has consistently been the first or second highest cause of cancer death over the past 20 years. This review article describes the progress of liver resection for HCC in Taiwan in the past half century. The mortality rate for HCC resection was 15-30% in Taiwan in the 1970s. The rate decreased to 8-12% in the early 1990s, and it declined to <1-3% recently. The development of new operative instruments, and surgical techniques, increased knowledge of liver anatomy and pathophysiology after hepatectomy, and more precise patient selection have contributed to this improvement. The use of intermittent hepatic inflow blood occlusion, a restrictive blood transfusion policy and intraoperative ultrasonography, have also led to substantial improvements in resectability and safety for HCC resection in Taiwan. Advances in non-operative modalities for HCC treatment have also helped to improve long-term outcomes of HCC resection. Technical innovations have allowed the application of complex procedures such as mesohepatectomy, unroofing hepatectomy, major portal vein thrombectomy, hepatic vein reconstruction in resection of the cranial part with preservation of the caudal part of the liver, and inferior vena cava and right atrium tumor thrombectomy under cardiopulmonary bypass. In selected patients, including patients with end-stage renal failure, renal graft recipients, patients with portal hypertension, hypersplenic thrombocytopenia and/or associated gastroesophageal varices, octogenarian, ruptured HCC, recurrent HCC and metastatic HCC can also be resected with satisfactory survival benefits. We conclude that the results of liver resection for HCC in Taiwan are improving. The indications for HCC resection continue extending with lower the surgical risks and increasing the long-term survival rate.
Introduction
Hepatocellular Carcinoma (HCC) is a highly lethal malignancy with an increasing prevalence worldwide (1) . It was ranked the third leading cause of cancer death recently (1, 2) . Taiwan is a wellknown endemic area of hepatitis B (3), and HCC has consistently remained the first or second highest cause of cancer death in the past 20 years (4) in spite of a nation-wide infant hepatitis B vaccination program (5) .
Although various non-operative treatment modalities for HCC have been developed (2, 6, 7) , liver resection is still a curative option for HCC. However, liver resection remains a complex surgical procedure (8) . Recently, the operative mortality in most high volume centers has been reduced to <1-3%, but the postoperative morbidity remains high, with a rate of >40% (6, 8) .
In Taiwan, the number of public tertiary medical centers is four in the north, one in the central region, and two in the south. As the only tertiary referral public medical center in central Taiwan, we treat HCC patients with a wide range of disease stages. It is therefore crucial to extend the indication, improve the safety, and increase the long-term survival of liver resection for HCC. In the past two decades, there have been considerable advances in HCC resection in Taiwan. In this review, we searched for studies on liver resection for HCC that were conducted in Taiwan from 1960 to the present. The aim of this review was to describe the historical progress and determine the trends of HCC resection in Taiwan, and to predict future developments.
Prior to the end of the Second World War, Taiwan was governed by Japan, and during this period there were very few studies on liver resection from Taiwan. Therefore, in this review, we searched for articles on liver resection for HCC performed in Taiwan institutions which were published after 1960. These articles included innovations, strategies, and prognosis of improvement following liver resection for HCC in Taiwan. Other modalities for HCC treatment were not included in this review. Laparoscopic liver resections with or without robotic assistance were also excluded because of different approach routes. Moreover, we also excluded liver transplantation for HCC due to different issue. We describe herein the course of the development of various operative methods for liver resection for HCC during the period from 1960 to the present. The merits and demerits of these methods are described and analyzed.
Improvements in safety of liver resection for HCC in Taiwan
The operative mortality of liver resection for HCC exceeded 15-30% in the 1970 s in Taiwan (9-13). It gradually declined to 8-12% in the early 1990 s (11, 14) . Since 2000, the mortality of liver resection has decreased to <1-3% (15, 16) . Hemorrhage and liver failure are the well-know lethal complications after liver resection (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . These factors influence each other. Controlling these factors improves the safety of liver resection.
Reduction of blood loss in HCC resection
Reduction of blood loss is paramount in liver resection. The great the amount of blood loss, the higher the operative morbidity and mortality rate (20) . There are two strategies for reducing blood loss during liver transaction.
Reduction of hemorrhage by liver parenchyma compression
The late Professor TY Lin may be regarded as the leading pioneer of liver surgery in Taiwan. More than half a century ago, he developed two famous techniques for liver resection, which were important milestones in the evolution of liver surgery in Taiwan (9-11). He created a liver clamp (Lin's liver clamp) which is made of soft metal (9) . The clamp can lightly compress the liver parenchyma as well as intrahepatic vessels. The shape of the design is in the form of a curved blade which corresponds to the curve of the liver surface (Fig. 1) . This instrument was widely used in institutions around the world for several decades. The clamp applies a gentle compressive force to the liver parenchyma to achieve a hemostatic effect. Although Lin's clamp is no longer commonly used in Taiwan owing to its limitations, some surgeons in southern Taiwan use it to teach liver resection techniques to trainee liver surgeons with good results (21) .
Using a similar concept of liver parenchyma compression, Chang et al. designed a needle with a hook at its tip that can pierce the liver parenchyma without causing injury to major intrahepatic vessels (Chang's needle) (22) . A silk thread is held by the hook. The needle punctures and pierces the liver parenchyma and the silk can be pulled out through the liver parenchyma. Then, the liver is transected after these stitches have been fastened so that bleeding from the liver cut surface can be reduced.
These methods are excellent for reducing hemorrhage during hepatectomy for peripherally-located HCC in non-cirrhotic liver or mild cirrhotic liver. However, for centrally located HCC in severely cirrhotic livers, these procedures are always ineffective at controlling bleeding. In the final paper of his career, Lin suggested that centrally located tumors (defined as Couinaud's segments 4, 5, 8) in cirrhotic livers are contraindicated for resection (11) . For severe cirrhotic liver with a deeply-seated HCC, the application of the aforementioned instruments is challenging because it is difficult to accurately apply compression force to reduce blood loss. Moreover, in patients with abnormal body stature (i.e. extremely obese, tall or short), due to fixed size of Lin's clamp or blind puncture of Chang's needle causes using these instruments difficult.
Reduction of hemorrhage by liver inflow blood occlusion More than 100 years ago, Pringle demonstrated that occlusion of blood inflow to the liver by clamping the hepatic hilar vessels could largely decrease the blood loss in liver trauma (23) . However, prolonged use of the maneuver causes intestinal congestion and liver cell ischemia-reperfusion injury and possibly even death. No survivors were noted in Pringle's report. At present, the upper tolerance of liver ischemia duration is unknown. Investigators from South Africa (24) and the UK (25) have demonstrated that the normal liver can tolerate total liver ischemia for 2 h. A randomized study conducted in Hong Kong (26) showed that intermittent use of Pringle's clamp significantly reduced blood loss in liver resection. Another randomized study from France (27) showed that continuous use of Pringle's method was more dangerous than intermittent use. We reviewed our experience of liver resection in cirrhotic patients and found that if the remnant liver was sufficiently preserved, prolonged intermittent Pringle clamping (clamping for 15 min and declamping for 5 min) up to 204 min was still safe in cirrhotic patients (28) .
Approximately 30 years ago, Makuuchi et al. in Japan, proposed a hemihepatic clamp technique to occlude the ipsilateral side of the liver (clamping for 30 min and declamping for 5 min) in hepatectomy for ipsilateral liver tumor with a wide liver transection plane (29) . In Taiwan, Chau et al. undertook a retrospective review of their liver resection cases and concluded that both Pringle clamping and hemihepatic clamping techniques significantly reduced blood loss in liver resection. A prospective randomized comparison of both intermittent hemi-or total occlusion of hepatic blood inflow in various liver resections with a wide liver transection plane (estimated transection plane >60 cm 2 ) revealed that hemihepatic clamping technique had lower blood loss and less magnitude of postoperative serum transaminase elevation (30) . Nevertheless, we think that both total and hemihepatic inflow occlusion are indispensible techniques in liver resection today. In addition, low central venous pressure during liver transaction by anesthesiologist is also essential to reduce blood loss (20) .
Reduction of blood transfusion in HCC resection
Patients with chronic hepatitis or cirrhosis can tolerate some degree of anemia. Massive blood transfusion increases the incidence of intestinal bacterial translocation, and causes a higher rates of infectious complication after cirrhotic liver resection (15, 17, 31) . If blood transfusion can be reduced, even systemic antibiotics are not necessary after liver resection (17) . Furthermore, blood transfusion is a poor prognosticator after liver resection for HCC (15) . Therefore, avoiding operative blood transfusion is also a key goal in HCC resection (18) .
Besides the use of hepatic pedicle occlusion to reduce operative blood loss, it is possible to reduce blood transfusion using a 'restrictive blood transfusion policy' (18) . Because there are abundant lymphatic vessels around the diseased liver, hepatic resection may cause destruction of these lymphatic vessels leading to loss of lymph. The lost lymph fluid is usually counted as blood loss in the operative theater. Blood loss to 1650 ml without blood transfusion has been experienced after cirrhotic liver resection (18) . In fact, the leaked lymphatic fluid was not true blood loss. Red-cell transfusion was only performed when the hemoglobin level was <8 g/dl or hematocrit was <24% (18) .
Ten years ago, we performed pharmacological hemostasis using an antifibrinolytic drug (32) . We administered a perioperative antifibrinolytic agent, tranexamic acid, in a double-blinded prospective randomized study, and demonstrated that a blood transfusion-free hepatectomy could be achieved in 108 consecutive patients, with a mean (range) transected liver surface area of 49.5 (8.8-148) cm 2 .
Avoidance of posthepatectomy liver failure
The most devastating complication after liver resection is posthepatectomy liver failure (19) . It is usually difficult to predict occurrences and outcomes in the perioperative period. Careful patient selection is mandatory to avoid the complications (19) .
Evaluation of patient liver function for HCC resection
A conservative policy should be adopted when considering the magnitude of liver resection. There is no internationally agreed consensus regarding liver resection extent and the criteria for the patient's liver function nowadays. The most commonly used evaluation of patient liver function for liver resection and portal hypertension management is the Child-Pugh score (33) . This patient selection criterion for liver resection is used in many institutions in Taiwan (34) (35) (36) (37) (38) . Only a small proportion of Child-Pugh grade B HCC patients were selected for liver resection. Child-Pugh grade C patients were usually contraindicated for liver resection. However, Child-Pugh grade can be subjective to some extent because there may be discrepancies among different surgeons based on various arbitrary considerations. For example, the definition of a moderate amount of ascites and moderate degree of encephalopathy are not always similar among different physicians. Moreover, the Child-Pugh criteria do not include comorbidities of the patients. Patients with chronic renal diseases had some degree of hypoalbuminemia with serum albumin level <2.8 g/dl. If a patient's renal disease is controllable, he may have good long-term survival. Thus, we treated several HCC patients with Child-Pugh grade C liver function who are still beneficial from liver resection. Thus, Child-Pugh grade C is not always considered as an absolute contraindication for HCC resection (39) .
The late Professor Lee proposed another criterion for selection of liver resection extent. He suggested that bromosulphalein 30 minretention rate <45%, resection of 310 g of liver can be safely performed (12) 
Indocyanine-green (ICG) has been widely used for evaluation of liver function, and has also been applied in evaluation for liver resection. Metabolism of ICG is similar to that of bilirubin excretion in bile except that ICG does not enter entero-hepatic circulation (19, 33, 40) . In 1993, Makuuchi et al. proposed a simple and useful patient selection criterion for small HCC resection (33) . In spite of controversial (19) , it is useful and easily to remember (20, 40 ). An acceptable mortality rate after cirrhotic liver resection is <1-3% (20,40). We have modified Makuuchi's criterion to improve the safety of cirrhotic liver resection (20) . The operative mortality for HCC resection reduced to <1% (15) . Some surgeons in Taiwan used MELD score as a patient selection criterion for cirrhotic liver resection, with satisfactory results (41).
Ligation or embolization of portal vein before liver resection
Ipsilateral portal vein ligation or embolization of affected liver lobe may cause atrophy of this lobe and compensatory hypertrophy of the opposite lobe in the liver. This procedure may increase the safety of extended major hepatectomy with insufficient liver remnant. In an animal experiment, not only the liver volume increased but also the hepatocyte function improved (42) . However, because HCC is usually associated with chronic hepatitis or cirrhosis in Taiwan, this procedure was not always performed because opposite lobe hypertrophy could not be guaranteed. Esophageal varices bleeding may occur in patients with portal hypertension (43) . Moreover, this procedure is expensive and not covered by national health insurance system (4, 44) . We prefer to perform a liver parenchyma preserving hepatectomy, such as hepatic vein reconstruction or unroofing hepatectomy (see below), in these circumstances. This procedure was only carried out in selected patients with liver hilar bile duct cancer in which extended major hepatectomy is needed to obtain curative resection (45) . Only animal experiment of this procedure was published (42) . No clinical studies on these procedures have been conducted in Taiwan.
Technical innovations in liver resection for HCC

Liver parenchyma transection techniques
In 1974, Prof. Lin also developed the finger-fracture technique for liver parenchyma transection (9) . Because the consistency of liver parenchyma is usually soft and intrahepatic vessels are usually harder than liver parenchyma, the surgeon can use his thumb and index finger to squeeze, crush and fracture the liver parenchyma while preserving the intrahepatic vessels and keeping them intact. Then, the vessels to the tumor part of the liver can be ligated and divided until the hepatectomy procedure is completed (9) . The late Professor Lee CS successfully used Lin's techniques to resect small HCC (<5 cm) located in the lateral part of the right lobe of the liver (12) . The results for HCC in the bilateral liver lobes were also encouraging as excellent results have been achieved (12) .
However, if the surgeon has thick fingers, fine intrahepatic dissection is difficult. Moreover, this technique is also challenging in cirrhotic liver resection.
Cavitron ultrasonic surgical aspirator (CUSA) is a widely modality used for liver parenchyma transection which, since 1990, has been adopted by most liver surgeons in Taiwan. However, in a controlled randomized trial by Takayama et al. (46) it was demonstrated that both CUSA dissection and Kelly clamp dissection of liver parenchyma had similar transection times and operative blood loss, but Kelly transection of liver may more readily cause dissection of fine intrahepatic vessels. We have always used the Kelly clamp for liver parenchyma transection.
Development of intraoperative ultrasonography
The development of intraoperative ultrasonography (IOUS) opened a new era in the field of liver surgery (47) . A number of new surgical procedures which utilize IOUS have been developed. IOUS was invented and first demonstrated by Makuuchi et al. in 1981 (48) . In Taiwan, Hsu et al. used it to detect the location of impalpable and invisible tumors in 1985 (49) . It allows the surgeon to clearly visualize the intrahepatic portal and hepatic veins. Since the Couinaud's liver segments are defined based on these veins, the actual location of each segment can be established from the liver surface. With the aid of IOUS, HCC resectability and resectional safety has been increased. We can find the exact location of intrahepatic major vessels (defined as right anterior, right posterior and left portal veins and three hepatic veins).
Therefore, a deeply impalpable and invisible HCC deeply adjacent to major intrahepatic vessels can be resected under 'unroofing hepatectomy' with the aid of IOUS without sacrificing too much non-tumorous liver (16) . The long-term outcomes of single nodular type HCC are better than those of other ordinary types of HCC (16) .
With the assistance of IOUS and intermittent hepatic inflow blood occlusion substantially increased the resectability (number of patients who underwent hepatectomy/number of patients referred for hepatectomy) of HCC. In our institution, the resectability of HCC rose from 12.1% before 1989 to 62.1% after 1990 (P < 0.0001) (49) . This trend was also observed in another institution in Taiwan (from 12% to 20% before 1980 to >30% after 1986) over the past 40 years (36,37).
Parenchyma-preserving hepatectomy
In 1987, resection of the cranial part of the right liver lobe, and right hepatic vein with preservation of the caudal part of this lobe was feasible if a thick right inferior hepatic vein was present (50) . However, this vein does not always appear. A simple criterion was proposed for deciding the necessity of hepatic vein reconstruction if the congested liver magnitude was >14.3% of the residual liver volume (approximately one Couinaud liver segment). The postoperative morbidity can be reduced if hepatic vein reconstruction is carried out (51) .
In the past, when an HCC was located in the central portion of the liver (Couinaud's segments 4, 5, 8), they were always resected by right or left trisectionectomy. Such procedures may create a large amount of functional liver loss, leading to high risk of posthepatectomy liver failure. With IOUS, it is possible to delineate the deep margin of the tumor, and maximal preservation of functional liver can be achieved. An HCC overriding the Cantlie's line can be resected by 'mesohepatectomy' (52). The long-term results are similar to those of extended right or left hepatectomy. We used the term 'mesohepatectomy' in 1999 to verify resection of Couinaud's segments 4, 5, 8 (53) . Four years later, another surgeon in Taiwan also described this procedure with the same results (34) . Recently, surgeons in a medical center in Taoyuan also published their experience of mesohepatectomy with satisfactory results (54) .
Removal of tumor thrombi in the major vessels or main bile duct
The blood supply of HCC is mostly from the hepatic artery and its drainage vein is the portal vein (29) . When tumor thrombi appear in major venous lumen, the prognosis is usually very poor. Therefore, liver resection is usually not recommended if tumor thrombi occupy the portal bifurcation or beyond to the main portal vein or contralateral portal vein. We have attempted to open the main portal vein wall, to remove the thrombus from the portal vein lumen or peel it off from the portal vein wall. The 5-year disease-free survival rate was 21% and the 5-year overall survival rate was 25% (55) . When HCC tumor thrombi extend to the inferior vena cava (IVC) or extend further to the right atrium or tricuspid valve, the prognosis is extremely poor. If untreated, the survival time will be less than several days as a result of the high incidence of sudden death due to thrombi occlusion of blood flow. Liver resection and thrombectomy with the assistance of cardiopulmonary bypass (CPB) is the only way to rescue the patient. Such a high risk operation is seldom performed as it is rarely indicated. We firstly performed the first concomitant hepatectomy and thrombectomy for a recurrent HCC patient using CPB and hypothermic total circulatory arrest because of dense hepatic hilum adhesion which precluded the Pringle maneuver. However, he survived only 14 months (56) . Recently, in Florence, Pesi et al. recommended this method to reduce operative blood loss, but their patients' survival times were also short (57) . We continue to explore new strategies and techniques which may overcome to these problems. Recently, Yeh et al. studied 30 HCC patients with main bile duct tumor thrombi who underwent curative resection and showed these patients had high rate of vascular invasion and poor. The prognoses of HCC with main bile duct tumor thrombi were also influenced by some oncogenes (58) .
Extending indications of HCC resection in particular circumstances
Changing resection strategies have enabled surgeons to perform operations for HCC that was previously considered high-risk and such procedures have gradually became more simplified and safe in recent years. In patients with end-stage renal disease (ESRD) who need hemodialysis (HD), heparin-free HD is inevitable during and after hepatectomy in order to avoid oozing blood from the liver transection plane and perihepatic raw surface due to systemic heparinization. We proposed a 1-week heparin-free HD strategy, and no 90-day postoperative mortality occurred (59) . A nationwide study was conducted thereafter and the results showed that although some operative mortality occurred, the long-term results were similar to those of non-ESRD patients (60) . The guidelines for treating HCC proposed by the Barcelona clinical liver cancer study group (BCLC) are used worldwide (1) . Portal hypertension is usually a contraindication for HCC resection by BCLC. However, with careful patient selection and perioperative assessments, patients with hypersplenic thrombocytopenia (defined as platelet count <8 × 10 4 /cumm) (61) or patients with severe esophageal varices (43) may also benefit from liver resection. Moreover, advanced age is not a contraindication for HCC resection, even for octogenarians (62) . HCC rupture is a critical condition. It may cause cancer cell intrabdominal seeding. The latest TNM system (63) grades this event at stage IV. Chen et al., however, reported some cases of long-term survival after HCC resection, but the operative mortality was 28% (13) . In the same hospital, Yeh et al. reported ruptured and non-ruptured HCC had similar long-term results with larger patient numbers (64) . In another institution, Chang et al. irrigated the abdominal cavity using distilled water after resection which prolonged survival in patients with ruptured HCC (35) .
For solitary recurrent HCC, Jeng et al. reported a good result after reresection (65) . Moreover, Lee et al. suggested that reresection or transarterial chemo embolization can prolong patient survival (37). Hu and Lee et al. analyzed 59 reresection cases for recurrent HCC. They found male sex, old age and tumor invasiveness negatively affected survival rates (36) . We also found that in patients with recurrent HCC, the second or third hepatectomy did not increase risks and had the same long-term results, compared with the first hepatectomy (66) .
Extrahepatic HCC metastasis is classified as M1, stage IV, in TNM staging system. The prognosis is usually poor. When HCC with peritoneum implantation, Yeh et al. observed good long-term survival after macroscopic total removal of the implant tumors (67, 68) . In 2004, another group of surgeons reported that six patients who had undergone metastectomy for lung metastasis of HCC had satisfactory long-term results (69) .
Conclusions
Liver resection techniques, equipment and safety have greatly improved since the middle of the 20th century. The strategies of liver resection have also helped to extend the indications and prolong long-term survival for HCC after liver resection. We believe that good shot and long-term results of liver resection for HCC will continue to progress, and new refinements in technique will allow surgeons to perform HCC resection in a wider range of patients.
